ZXDC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.019700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.373600E-01
Normal-vs-Stage2
5.310100E-02
Normal-vs-Stage3
1.561030E-01
Normal-vs-Stage4
7.089800E-01
Stage1-vs-Stage2
3.069900E-02
Stage1-vs-Stage3
1.174310E-04
Stage1-vs-Stage4
7.259800E-01
Stage2-vs-Stage3
9.697700E-03
Stage2-vs-Stage4
1.711220E-01
Stage3-vs-Stage4
1.934420E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.365800E-02
Normal-vs-AfricanAmerican
4.290600E-01
Normal-vs-Asian
1.489830E-01
Caucasian-vs-AfricanAmerican
5.857400E-01
Caucasian-vs-Asian
6.903000E-01
AfricanAmerican-vs-Asian
5.509200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.948000E-01
Normal-vs-Female
1.022820E-01
Male-vs-Female
6.481000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.472400E-01
Normal-vs-Age(41-60Yrs)
1.304770E-01
Normal-vs-Age(61-80Yrs)
4.882000E-02
Normal-vs-Age(81-100Yrs)
9.634000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.094000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.279000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.319000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.301700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.649600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.637600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.483420E-01
Normal-vs-Daily Drinker
9.437600E-02
Normal-vs-Weekly Drinker
6.781800E-02
Normal-vs-Occasional Drinker
2.424000E-01
Normal-vs-Social Drinker
2.102400E-01
Non Drinker-vs-Daily Drinker
7.991000E-01
Non Drinker-vs-Weekly Drinker
4.824800E-01
Non Drinker-vs-Occasional Drinker
5.448200E-01
Non Drinker-vs-Social Drinker
4.392400E-01
Daily Drinker-vs-Weekly Drinker
6.058600E-01
Daily Drinker-vs-Occasional Drinker
3.896200E-01
Daily Drinker-vs-Social Drinker
2.800800E-01
Weekly Drinker-vs-Occasional Drinker
2.127000E-01
Weekly Drinker-vs-Social Drinker
1.224190E-01
Occasional Drinker-vs-Social Drinker
8.689600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.117560E-01
Normal-vs-Grade 2
2.408200E-02
Normal-vs-Grade 3
2.003500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.687400E-01
Grade 1-vs-Grade 3
1.275030E-01
Grade 1-vs-Grade 4
1.117560E-01
Grade 2-vs-Grade 3
7.779800E-02
Grade 2-vs-Grade 4
2.408200E-02
Grade 3-vs-Grade 4
2.003500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.603700E-02
Normal-vs-NonDiabetic
8.361600E-02
Diabetic-vs-NonDiabetic
1.221770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.716800E-01
Normal-vs-NoPancreatitis
5.223800E-02
Pancreatitis-vs-NoPancreatitis
9.671500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.041960E-01
Normal-vs-N1
5.425500E-02
N0-vs-N1
8.151800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.116200E-01
Normal-vs-TP53-NonMutant
6.370600E-01
TP53-Mutant-vs-TP53-NonMutant
7.840000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
